Andrew Y. K. Foong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrew Y. K. Foong has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- David M. Routman
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
3 shared publications Federico Mastroleo
3 shared publications- Mariana Borras-Osorio
Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States
3 shared publications - Mark R. Waddle
Department of Radiation Oncology, Mayo Clinic, Rochester, USA
2 shared publications Renthony Wilson
Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States
2 shared publicationsSatomi Shiraishi
2 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by KEAI Publishing in Meta-Radiology
RadOnc-GPT: An Exploratory Feasibility Study of a Prototype LLM Agent for Radiation Oncology Outcomes Labeling and Registry Auditing
- 1 October 2026
- Published by KEAI Publishing in Meta-Radiology
Open AccessRadOnc-GPT: An Exploratory Feasibility Study of a Prototype LLM Agent for Radiation Oncology Outcomes Labeling and Registry Auditing
- Open Access
- 19 December 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 37, 100372
From BERT to GPT-4: A systematic review of AI-Driven toxicity extraction and grading in radiation oncology
- 19 December 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 37, 100372
Open AccessFrom BERT to GPT-4: A systematic review of AI-Driven toxicity extraction and grading in radiation oncology
- 18 December 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 216, 111348
Large language models for toxicity extraction in oncology trials: A real-world benchmark in prostate radiotherapy
- 18 December 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 216, 111348
Large language models for toxicity extraction in oncology trials: A real-world benchmark in prostate radiotherapy
- Open Access
Deep Learning Driven Field Dose Prediction for Head and Neck Cancer Treated with Spot Scanning Proton Therapy
Purpose: Accurate dose prediction is essential for automating radiotherapy planning. In spot scanning proton therapy (SSPT), dose evaluation is required at both the plan and field level. Evaluating individual treatment fields is critical to ensuring optimal beam angles are chosen to ensure target coverage and maximum organ-at-risk (OAR) sparing. Currently, however, no knowledge-based tools exist for predicting field-level doses for head and neck cancer (HNC) treated with SSPT. In this work, we aim to develop the first deep learning–based dose prediction model capable of field-level dose prediction for HNC treated with SSPT. Methods: A cohort of 62 HNC patients treated with SSPT was compiled for model development and evaluation. Collected patient data included treatment planning CTs, OAR masks, signed distance maps (SDMs), generated beam masks, and dose distributions. An encoder-decoder architecture enhanced with a cross-attention transformer bottleneck was used as the field prediction model. Comparison and ablation studies evaluated the model’s performance and determined the benefits of individual model components. Evaluation imaging metrics included mean absolute error, structural similarity index measure, and peak signal-to-noise ratio. Clinical performance was evaluated using dose-volume histogram metrics. Results: The best performing model from the ablation study was the full model using OAR masks, SDMs, generated beam masks and four-field dose prediction. The model outperformed the Distance Guided Dose Prediction (DGDP) and DeepLabV3 comparison models. The DGDP and DeepLabV3 comparison models had a mean validation set MAE performance of 1.268 Gy and 1.325 Gy, respectively, compared to our model’s mean validation set MAE performance of 0.949 Gy. The model’s final mean test set performance was MAE 1.024 Gy, SSIM 0.913, and PSNR 28.495 dB. Conclusions: We developed a cross-attention transformer–enhanced deep learning model that accurately predicts per-field dose for HNC treated with SSPT, demonstrating superior performance over state-of-the-art models limited to plan-level dose prediction.
Open AccessDeep Learning Driven Field Dose Prediction for Head and Neck Cancer Treated with Spot Scanning Proton Therapy
Purpose: Accurate dose prediction is essential for automating radiotherapy planning. In spot scanning proton therapy (SSPT), dose evaluation is required at both the plan and field level. Evaluating individual treatment fields is critical to ensuring optimal beam angles are chosen to ensure target coverage and maximum organ-at-risk (OAR) sparing. Currently, however, no knowledge-based tools exist for predicting field-level doses for head and neck cancer (HNC) treated with SSPT. In this work, we aim to develop the first deep learning–based dose prediction model capable of field-level dose prediction for HNC treated with SSPT. Methods: A cohort of 62 HNC patients treated with SSPT was compiled for model development and evaluation. Collected patient data included treatment planning CTs, OAR masks, signed distance maps (SDMs), generated beam masks, and dose distributions. An encoder-decoder architecture enhanced with a cross-attention transformer bottleneck was used as the field prediction model. Comparison and ablation studies evaluated the model’s performance and determined the benefits of individual model components. Evaluation imaging metrics included mean absolute error, structural similarity index measure, and peak signal-to-noise ratio. Clinical performance was evaluated using dose-volume histogram metrics. Results: The best performing model from the ablation study was the full model using OAR masks, SDMs, generated beam masks and four-field dose prediction. The model outperformed the Distance Guided Dose Prediction (DGDP) and DeepLabV3 comparison models. The DGDP and DeepLabV3 comparison models had a mean validation set MAE performance of 1.268 Gy and 1.325 Gy, respectively, compared to our model’s mean validation set MAE performance of 0.949 Gy. The model’s final mean test set performance was MAE 1.024 Gy, SSIM 0.913, and PSNR 28.495 dB. Conclusions: We developed a cross-attention transformer–enhanced deep learning model that accurately predicts per-field dose for HNC treated with SSPT, demonstrating superior performance over state-of-the-art models limited to plan-level dose prediction.